Bowen Gu joins panel at RI Asia Japan 2018
Date
11 April 2018
Bowen will join a panel exploring whether there is an investment case for the 17 Sustainable Development Goals (SDGs) developed by the United Nations and its member states. She will speak on the Foundation’s work on the Access to Medicine Index and analyses on material ESG issues, such as governance & compliance, pricing, patents and licensing, R&D and supply chain management. She will also describe how it aims to incentivise pharmaceutical companies to improve access to medicine in low- and middle-income countries and diffuses best practices within companies, governments and investors.